Individual Stock News
1. China Xuyang Group (01907.HK) plans to invest RMB 507 million in Xiangfu New Energy to help it rapidly expand its production capacity.
2. Nine Dragons Paper (02689.HK) released its annual results: profit attributable to shareholders was RMB 3.581 billion, an increase of 102.62% year-on-year.
3. Vision Holdings (00862.HK) released its annual results: loss attributable to shareholders was HKD 437 million, an increase of 678.29% year-on-year.
4. Estun (02715.HK) plans to acquire approximately 44.8601% of Estun Jiangsu Intelligent's shares, increasing its stake to approximately 95.0107%.
5. Fosun Pharma (02696.HK) entered into a cooperation and licensing agreement with Amberstone for two T-cell connector products.
6. Asia Pacific Resources (01104.HK) released its annual results: profit attributable to shareholders was HK$1.711 billion, an increase of 601.69% year-on-year.
7. Hengrui Medicine (01276.HK): HRS-7172 tablets, adebelimab injection, and other drugs received drug clinical trial approval notices.
8. Lepu Biopharma (02157.HK): The clinical study results of CMG901 (AZD0901) were selected for the LBA and will be announced at the Chairman's Symposium. A total of 4 clinical study results were selected for the 2026 ESMO Congress.
